Analytical strategies for pharmaceutical products
Chromatography and MS are extensively used in the formulation development stage of generic drug products. The ICH Q3B guidelines address the reporting threshold, identification threshold, and qualification threshold for impurities in the drug product. Chromatography (LC) and Gas Chromatography (GC) are extensively used to analyze stable compounds. However, for labile compounds require derivatization prior to LC or GC analysis. For certain selected analyses, Liquid Chromatography- Ultraviolet Detection (LC-UVD) and Gas Chromatography-Flame Ionization Detection (GC-FID) techniques may be deemed suitable. However, Liquid Chromatography-Mass Spectrometry (LC-MS) and Gas Chromatography-Mass Spectrometry (GC-MS) are usually the techniques of choice when higher specificity and sensitivity are required. Gas Chromatography-Electron Capture Detection (GC-ECD)techniques are commonly used for halogenated PGIs/GIs to enhance sensitivity and selectivity. Occasionally, some spectroscopic techniques like Nuclear Magnetic Resonance (NMR), light scattering, and Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) are used in analyzing PGIs/GIs.
- • Analytical Strategies in the development of Generics
- • Analytical strategies for Biosimilars
- • Analytical strategies for Genotoxic impurities
- • Analytical method transfer of pharmaceuticals
- • Integrated analytical strategies for drug discovery
Related Conference of Analytical strategies for pharmaceutical products
November 19-20, 2026
14th International Conference and Exhibition on Natural Products and Medicinal Plants Research
Dubai, UAE
November 26-27, 2026
5th World Conference on Pharma Industry and Medical Devices
Zurich, Switzerland
December 14-15, 2026
5th International Conference and Expo on Pharmaceutics & Novel Drug Delivery Systems
Amsterdam, Netherlands
December 28-29, 2026
15th International Conference on Clinical Research & Clinical Trials
London, UK
February 15-16, 2027
18th International Conference on Pharmaceutical Education and Practice
Rome, Italy
February 15-16, 2027
9th International Conference on Pharmaceutical Research
&
Innovations in Pharma Industry
Rome, Italy
April 01-02, 2027
13th International Conference on Antimicrobials & Antibiotic Resistance
Madrid, Spain
April 29-30, 2027
26th International Conference on Medicinal and Pharmaceutical Chemistry
Geneva, Switzerland
April 29-30, 2027
9th International Conference and Exhibition on Pharmaceutical Development and Technology
Geneva, Switzerland
May 24-25, 2027
21st International Conference on Pharmaceutical Formulations & Drug Delivery
Tokyo, Japan
May 26-27, 2027
20th International Conference and Exhibition on Pharmacovigilance & Drug Safety
Rome, Italy
June 24-25, 2027
33rd International Conference on Advanced Clinical Research and Clinical Trials
Madrid, Spain
Analytical strategies for pharmaceutical products Conference Speakers
Recommended Sessions
- Analytical strategies for pharmaceutical products
- Business Opportunities in Drug Delivery
- challenges in pharmaceutical research and development
- Global Market & Pharmaceutical Formulation
- Importance of Audit in Pharmaceutical Industry
- Major challenges in Drug Delivery
- Nano Pharmaceutics and Advanced Drug Delivery
- Nanotechnology in Drug Delivery
- Pharmaceutical Research and Development
- regulatory challenges in pharmaceutical industry
- Use of Nanoparticles in DDS and Newer Methodologies
Related Journals
Are you interested in
- Pharmaceutical Chemistry and Medicinal Chemistry - PHARMA CONFERENCE 2026 (Spain)
- 3D Printing in Pharmaceutical Formulations - Drug Devilvery 2027 (France)
- Active Pharmaceutical Ingredients - MedTech-2026 (Switzerland)
- Acupuncture - Naturalproducts 2026 (UAE)
- Advanced Biostatistics, Modeling & Simulation in Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Advanced Drug Delivery Systems - Drug Devilvery 2027 (France)
- Advanced Drug Delivery Systems - PHARMA EDUCATION 2027 (Italy)
- Advanced Drug Delivery Systems & Technologies - Drug Delivery 2027 (Austria)
- Advanced Drug Delivery Systems and Novel Formulation Strategies - Drug Safety 2027 (Italy)
- Advanced Pharmaceutical Analytical Technologies - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Advanced Pharmaceutical Research - PHARMA CONFERENCE 2026 (Spain)
- Advanced Pharmacokinetics - Pharmaceuticals-2027 (France)
- Advancements in Drug Delivery Systems - Pharmaceutica-2026 (Netherlands)
- Advances in Clinical Trial Design & Methodologies - EURO CLINICAL TRIALS 2026 (UK)
- Advances in Controlled Release Formulations - Pharmaceutica-2026 (Netherlands)
- Advances in Ocular Drug Delivery - Pharmaceutica-2026 (Netherlands)
- Advances in Pharmaceutical Analysis and Analytical Techniques - Drug Safety 2027 (Italy)
- Alternative Medicine and Complementary Medicine - Naturalproducts 2026 (UAE)
- Analytical strategies for pharmaceutical products - MedTech-2026 (Switzerland)
- Antimicrobial Drug Discovery and Development - Antibiotics Resistance 2027 (Spain)
- Antimicrobial Stewardship and Rational Antibiotic Use - Antibiotics Resistance 2027 (Spain)
- Antiplatelet and Anticoagulant Pharmacology - Cardiovascular-2027 (France)
- Arrhythmias and Antiarrhythmic Drug Therapy - Cardiovascular-2027 (France)
- Artificial Intelligence (AI) - Personalizedmedicine-2026 (Switzerland)
- Artificial Intelligence and Digital Tools for Rare Disease Diagnosis - ORPHAN DRUGS 2026 (France)
- Artificial Intelligence and Digital Transformation in Pharmaceutics - Drug Safety 2027 (Italy)
- Artificial Intelligence and Machine Learning in AMR Research - Antibiotics Resistance 2027 (Spain)
- Artificial Intelligence and Machine Learning in Drug Delivery - Drug Devilvery 2027 (France)
- Artificial Intelligence and Machine Learning in Drug Delivery Optimization - Pharmaceutica-2026 (Netherlands)
- Artificial Intelligence in Pharma - Pharmaceuticals-2027 (France)
- Artificial Intelligence in Pharmaceutical Sciences - PHARMA CONFERENCE 2026 (Spain)
- Artificial Intelligence in Pharmacy - PHARMA EDUCATION 2027 (Italy)
- Artificial Intelligence, Digital Transformation, and Data Science in Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Artificial Intelligence, Machine Learning & Digital Drug Delivery - Drug Delivery 2027 (Austria)
- Artificial Intelligence, Machine Learning & Digital Innovations in Clinical Research - EURO CLINICAL TRIALS 2026 (UK)
- Atrial Fibrillation and Stroke Prevention - Cardiovascular-2027 (France)
- BCS and IVIVC Based Biowaivers - Eurobiosimilars 2027 (Italy)
- Bio-Pharmaceutical Sciences - Pharmaceuticals-2027 (France)
- Bioequivalence and Bioavailability - MedTech-2026 (Switzerland)
- Biological Medicine - Eurobiosimilars 2027 (Italy)
- Biologics and Biosimilars - Pharmaceutica-2026 (Netherlands)
- Biologics, Gene, and RNA Therapeutics - Drug Devilvery 2027 (France)
- Biologics, Peptides, Proteins & Vaccine Delivery - Drug Delivery 2027 (Austria)
- Biomarkers - Personalizedmedicine-2026 (Switzerland)
- Biopharmaceutical Informatics - Eurobiosimilars 2027 (Italy)
- Biopharmaceuticals & Advanced Therapeutics - PHARMA EDUCATION 2027 (Italy)
- Biopharmaceuticals and Biosimilars - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Biopharmaceuticals and Protein Delivery - Drug Devilvery 2027 (France)
- Biopharmaceutics and Drug Disposition - Pharmaceutica-2026 (Netherlands)
- Biopharmaceutics and Pharmacokinetics - PHARMA CONFERENCE 2026 (Spain)
- Biopharmaceutics and Pharmacokinetics in Drug Development - Drug Safety 2027 (Italy)
- Biosimilars and Generic Drug Development - Drug Safety 2027 (Italy)
- Biosimilars Approval to Biogenerics in Clinical Practice - Eurobiosimilars 2027 (Italy)
- Biosimilars Development in Markets - Eurobiosimilars 2027 (Italy)
- Biosimilars Market and Cost Analysis - Eurobiosimilars 2027 (Italy)
- Biosimilars Research Pipeline - Eurobiosimilars 2027 (Italy)
- Blockchain & Data Security in Clinical Research - EURO CLINICAL TRIALS 2026 (UK)
- Brain & CNS Drug Delivery - Drug Delivery 2027 (Austria)
- Cancer Pharmacology - Euro Pharmacology 2027 (France)
- Cardio-Oncology Pharmacology - Cardiovascular-2027 (France)
- Cardiovascular Drug Discovery and Development - Cardiovascular-2027 (France)
- Cardiovascular Drug Safety and Pharmacovigilance - Cardiovascular-2027 (France)
- Cardiovascular Pharmacology - Euro Pharmacology 2027 (France)
- Cardiovascular Pharmacology and Therapeutics - Cardiovascular-2027 (France)
- Cardiovascular Pharmacology in Women’s Health - Cardiovascular-2027 (France)
- Challenges and Future Innovations of Traditional Medicine - Naturalproducts 2026 (UAE)
- Challenges in Biosimilars Pharmacovigilance - Eurobiosimilars 2027 (Italy)
- Challenges In Pharmaceutical Formulations - Pharmatech 2027 (Switzerland)
- Chemical and Analytical Strategies for Biosimilars - Eurobiosimilars 2027 (Italy)
- Clinical Data Management, Biostatistics & AI Applications - EURO CLINICAL TRIALS 2026 (UK)
- Clinical Microbiology and Infectious Disease Management - Antibiotics Resistance 2027 (Spain)
- Clinical Pharmacology - Pharmaceuticals-2027 (France)
- Clinical Pharmacology and Drug Interactions - Drug Safety 2027 (Italy)
- Clinical Pharmacology and Therapeutics - Euro Pharmacology 2027 (France)
- Clinical Pharmacy & Patient-Centered Care - PHARMA EDUCATION 2027 (Italy)
- Clinical Pharmacy and Patient Care - PHARMA CONFERENCE 2026 (Spain)
- Clinical Pharmacy and Pharmacy Practices - MedTech-2026 (Switzerland)
- Clinical Research and Translational Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Clinical Toxicology and Poison Management - Euro Pharmacology 2027 (France)
- Clinical Trials - Personalizedmedicine-2026 (Switzerland)
- Clinical Trials and Evidence-Based Research - PHARMA CONFERENCE 2026 (Spain)
- Clinical trials and Pharmacovigilance - MedTech-2026 (Switzerland)
- Clinical Trials and Real-World Evidence in Cardiovascular Pharmacology - Cardiovascular-2027 (France)
- Clinical Trials and Regulatory Affairs in Drug Development - Drug Safety 2027 (Italy)
- Clinical Trials in Medical Devices - EURO CLINICAL TRIALS 2026 (UK)
- Combination Drug Delivery Systems - Drug Devilvery 2027 (France)
- Computational Chemistry and Artificial Intelligence - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Computational Pharmacology and Artificial Intelligence - Euro Pharmacology 2027 (France)
- Consequences of Brexit on Biosimilars - Eurobiosimilars 2027 (Italy)
- Controlled and Sustained Release Formulations - Drug Devilvery 2027 (France)
- Coronary Artery Disease and Anti-Ischemic Drugs - Cardiovascular-2027 (France)
- COVID-19 & Emerging Infectious Diseases Clinical Research - EURO CLINICAL TRIALS 2026 (UK)
- CRISPR-Cas9 and Gene Editing Delivery - Drug Devilvery 2027 (France)
- Crude Drugs and Plant Products - Naturalproducts 2026 (UAE)
- Current Agency Expectations for Approval for Biosimilars - Eurobiosimilars 2027 (Italy)
- Current Challenges in Developing Biosimilars - Eurobiosimilars 2027 (Italy)
- Data Analytics - Personalizedmedicine-2026 (Switzerland)
- Diabetes, Metabolic Disorders and Cardiovascular Pharmacology - Cardiovascular-2027 (France)
- Digital Health - Personalizedmedicine-2026 (Switzerland)
- Digital Health, AI and Cardiovascular Pharmacology - Cardiovascular-2027 (France)
- Digital Health, Telemedicine & Remote Monitoring in Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Digital Pharma - Pharmatech 2027 (Switzerland)
- Digital Pharmacy & Smart Healthcare - PHARMA EDUCATION 2027 (Italy)
- Disease Prevention - Personalizedmedicine-2026 (Switzerland)
- Drug Delivery and Development - Eurobiosimilars 2027 (Italy)
- Drug Delivery and Gene Therapy - Pharmaceutica-2026 (Netherlands)
- Drug Delivery Challenges in Special Populations - Drug Safety 2027 (Italy)
- Drug Delivery for Cancer & Immunotherapy - Drug Delivery 2027 (Austria)
- Drug Delivery for Cardiovascular Diseases - Pharmaceutica-2026 (Netherlands)
- Drug Delivery in Cancer Therapy - Pharmaceutica-2026 (Netherlands)
- Drug Delivery in Infectious Diseases - Pharmaceutica-2026 (Netherlands)
- Drug Development & Translational Research - EURO CLINICAL TRIALS 2026 (UK)
- Drug Discovery - Pharmaceuticals-2027 (France)
- Drug Discovery & Development - PHARMA EDUCATION 2027 (Italy)
- Drug Discovery and Development - Pharmatech 2027 (Switzerland)
- Drug Discovery and Development - Euro Pharmacology 2027 (France)
- Drug Discovery and Medicinal Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Drug discovery and NCEs - MedTech-2026 (Switzerland)
- Drug formulation - Pharmaceuticals-2027 (France)
- Drug Interactions and Polypharmacy in Cardiovascular Care - Cardiovascular-2027 (France)
- Drug Market access - Pharmaceuticals-2027 (France)
- Drug Metabolism - Pharmaceuticals-2027 (France)
- Drug Product Manufacturing - Pharmatech 2027 (Switzerland)
- Drug Regulatory Compliance - Pharmaceuticals-2027 (France)
- Drug Safety, Pharmacovigilance, and Risk Management - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Drug screening - Pharmaceuticals-2027 (France)
- Drug Stability Studies and Shelf Life Determination - Drug Safety 2027 (Italy)
- Drug Targeting and Design - Pharmaceutica-2026 (Netherlands)
- Drug Targeting and Design - Pharmatech 2027 (Switzerland)
- Electronic Health Records (EHRs) - Personalizedmedicine-2026 (Switzerland)
- Emerging Biosimilars in Therapeutics - Eurobiosimilars 2027 (Italy)
- Emerging Cardiovascular Therapies and Future Pharmacological Strategies - Cardiovascular-2027 (France)
- Emerging Drug Delivery Routes and Non-Invasive Technologies - Drug Safety 2027 (Italy)
- Emerging Technologies and Smart Drug Delivery - Drug Devilvery 2027 (France)
- Emerging Trends and Future Directions in Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Emerging Trends in Personalized Medicine and Targeted Therapy - Drug Safety 2027 (Italy)
- Emerging Trends in Pharmaceutical Sciences - PHARMA CONFERENCE 2026 (Spain)
- Emerging Trends in Pharmacology - Euro Pharmacology 2027 (France)
- Endocrine Pharmacology - Euro Pharmacology 2027 (France)
- Environmental and Agricultural Impact on AMR Spread - Antibiotics Resistance 2027 (Spain)
- Environmental Toxicology - Euro Pharmacology 2027 (France)
- Ethical, Legal, and Social Issues (ELSI) in Rare Disease Research - ORPHAN DRUGS 2026 (France)
- Ethics, IRB & Patient Safety in Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Ethics, Sustainability, and Social Responsibility in Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Exosome-Based Drug Delivery - Drug Devilvery 2027 (France)
- Experimental Pharmacology - Euro Pharmacology 2027 (France)
- Forensic Toxicology - Euro Pharmacology 2027 (France)
- Formulation Strategies for Follow-on Biologics - Eurobiosimilars 2027 (Italy)
- Formulations and NNDS - MedTech-2026 (Switzerland)
- Future Directions, Personalized Delivery & Translational Drug Delivery - Drug Delivery 2027 (Austria)
- Future Innovations & Emerging Trends in Clinical Research - EURO CLINICAL TRIALS 2026 (UK)
- Future Outlook and Innovations in Next-Generation Therapeutics - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Future Perspectives in Pharmaceutics and Drug Safety - Drug Safety 2027 (Italy)
- Future Trends in Pharmacy Practice - PHARMA EDUCATION 2027 (Italy)
- Gene & Cell Therapy Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Gene and RNA-Based Cardiovascular Therapies - Cardiovascular-2027 (France)
- Gene Editing and CRISPR Delivery - Drug Devilvery 2027 (France)
- Gene Therapy and CRISPR Technologies in Rare Disease Treatment - ORPHAN DRUGS 2026 (France)
- Gene, RNA & Nucleic Acid Delivery - Drug Delivery 2027 (Austria)
- Genetic Testing - Personalizedmedicine-2026 (Switzerland)
- Genomics - Personalizedmedicine-2026 (Switzerland)
- Genomics & Next-Generation Sequencing in Rare Diseases - ORPHAN DRUGS 2026 (France)
- Genomics, Bioinformatics and AMR Surveillance - Antibiotics Resistance 2027 (Spain)
- Geriatric Cardiovascular Pharmacology - Cardiovascular-2027 (France)
- Global Challenges and Future Perspectives in Pharmacology and Toxicology - Euro Pharmacology 2027 (France)
- Global Collaboration, Future Trends & Innovations in Clinical Research - EURO CLINICAL TRIALS 2026 (UK)
- Global Epidemiology and Disease Burden in Rare Conditions - ORPHAN DRUGS 2026 (France)
- Global Trends in Antimicrobial Resistance (AMR) - Antibiotics Resistance 2027 (Spain)
- Globalization of Biosimilars - Eurobiosimilars 2027 (Italy)
- Green and Sustainable Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Health Equity - Personalizedmedicine-2026 (Switzerland)
- Heart Failure Pharmacology - Cardiovascular-2027 (France)
- Herbal Medicine - Naturalproducts 2026 (UAE)
- Herbal Medicine and Natural Products Research - PHARMA CONFERENCE 2026 (Spain)
- Homeopathic and Ayurvedic Medicines - Naturalproducts 2026 (UAE)
- Hospital and Community Pharmacy Practice - PHARMA CONFERENCE 2026 (Spain)
- Hospital-Acquired and Healthcare-Associated Infections (HAIs) - Antibiotics Resistance 2027 (Spain)
- Hydrogel-Based Drug Delivery - Drug Devilvery 2027 (France)
- Hypertension and Antihypertensive Therapy - Cardiovascular-2027 (France)
- Imaging-Guided Drug Delivery - Drug Devilvery 2027 (France)
- Immunopharmacology - Euro Pharmacology 2027 (France)
- Immunotherapy and Targeted Cancer Therapies - Drug Devilvery 2027 (France)
- Industrial Pharmacy and Manufacturing Technologies - PHARMA CONFERENCE 2026 (Spain)
- Infection Prevention and Control (IPC) Strategies - Antibiotics Resistance 2027 (Spain)
- Injectable and Parenteral Drug Delivery - Drug Devilvery 2027 (France)
- Injectable, Implantable & Controlled-Release Systems - Drug Delivery 2027 (Austria)
- Innovations In Pharmaceutical Technology - Pharmatech 2027 (Switzerland)
- Innovative Clinical Approach in Biosimilars - Eurobiosimilars 2027 (Italy)
- Innovative Therapeutics & Novel Drug Delivery Systems - EURO CLINICAL TRIALS 2026 (UK)
- Intellectual Property Rights - Eurobiosimilars 2027 (Italy)
- Intellectual Property, Patents, and Technology Transfer - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Legal Issues and BPCI Act - Eurobiosimilars 2027 (Italy)
- Lifestyle Medicine - Personalizedmedicine-2026 (Switzerland)
- Lipid Management and Cardiovascular Prevention - Cardiovascular-2027 (France)
- Lipid Nanoparticles, Liposomes & Lipid-Based Delivery - Drug Delivery 2027 (Austria)
- Marine Natural Products - Naturalproducts 2026 (UAE)
- Mechanisms of Antimicrobial Resistance in Pathogens - Antibiotics Resistance 2027 (Spain)
- Medical Pharmacology - Pharmaceuticals-2027 (France)
- Medicinal Chemistry - Naturalproducts 2026 (UAE)
- Medicinal Plant Research - Naturalproducts 2026 (UAE)
- Medicinal Plants as Anti-Cancer Drugs - Naturalproducts 2026 (UAE)
- Microbiome-Based Drug Delivery - Drug Devilvery 2027 (France)
- Microfluidics and Lab-on-a-Chip Systems in Drug Formulation - Drug Devilvery 2027 (France)
- Molecular and Cellular Pharmacology - Euro Pharmacology 2027 (France)
- Molecular Diagnostics in Infectious Diseases - Antibiotics Resistance 2027 (Spain)
- Monoclonal Antibody Biosimilars - Eurobiosimilars 2027 (Italy)
- mRNA and Nucleic Acid Therapeutics - Drug Devilvery 2027 (France)
- Nano medicine and Nanotechnology in Drug Delivery - Pharmaceutica-2026 (Netherlands)
- Nanomedicine & Nanoparticle-Based Drug Delivery - Drug Delivery 2027 (Austria)
- Nanomedicine and Advanced Drug Delivery - Cardiovascular-2027 (France)
- Nanomedicine and Nanotechnology in Drug Delivery - Drug Devilvery 2027 (France)
- Nanopharmacology and Drug Delivery - Euro Pharmacology 2027 (France)
- Nanotechnology & Nanomedicine - PHARMA EDUCATION 2027 (Italy)
- Nanotechnology and Nanomedicine - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Nanotechnology in Drug Delivery - PHARMA CONFERENCE 2026 (Spain)
- Nanotechnology in Drug Delivery and Therapeutics - Drug Safety 2027 (Italy)
- Natural Products - Naturalproducts 2026 (UAE)
- Natural Products and Herbal Drug Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Natural Products and Herbal Pharmacology - Euro Pharmacology 2027 (France)
- Natural Products Chemistry - Naturalproducts 2026 (UAE)
- Neuropharmacology - Euro Pharmacology 2027 (France)
- New Sources and Approaches to Natural Products - Naturalproducts 2026 (UAE)
- Novel Antibiotics and Next-Generation Therapeutics - Antibiotics Resistance 2027 (Spain)
- Novel Drug Delivery Systems and Formulation Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Novel Drug Delivery Systems, Biomarkers & Drug Targets - MedTech-2026 (Switzerland)
- Novel Drug Delivery Technologies - Pharmaceutica-2026 (Netherlands)
- Novel Drug Discovery and Development Approaches - Drug Safety 2027 (Italy)
- Nutraceuticals & Functional Medicine - Naturalproducts 2026 (UAE)
- Obesity Pharmacotherapy and Cardiovascular Risk - Cardiovascular-2027 (France)
- Occupational Health and Industrial Toxicology - Euro Pharmacology 2027 (France)
- One Health Approach to Antimicrobial Resistance - Antibiotics Resistance 2027 (Spain)
- Oral Drug Delivery Innovations - Drug Devilvery 2027 (France)
- Oral, Transdermal & Mucosal Drug Delivery - Drug Delivery 2027 (Austria)
- Orphan Drug Discovery and Development Strategies - ORPHAN DRUGS 2026 (France)
- Orphan Drugs and Rare Disease Drug Delivery - Drug Devilvery 2027 (France)
- Orphan Drugs and Rare Disease Therapeutics - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Patient Recruitment, Retention & Engagement Strategies - EURO CLINICAL TRIALS 2026 (UK)
- Patient-Cantered Care - Personalizedmedicine-2026 (Switzerland)
- Pediatric and Geriatric Pharmacology - Euro Pharmacology 2027 (France)
- Pediatric Cardiovascular Pharmacology - Cardiovascular-2027 (France)
- Pediatric, Geriatric, and Targeted Therapeutics - Drug Devilvery 2027 (France)
- Peptide and Protein Drug Delivery - Pharmaceutica-2026 (Netherlands)
- Personalized & Precision Medicine - PHARMA EDUCATION 2027 (Italy)
- Personalized and Precision Medicine - PHARMA CONFERENCE 2026 (Spain)
- Personalized Healthcare - Personalizedmedicine-2026 (Switzerland)
- Personalized Medicine and Precision Therapeutics - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Personalized Medicine, Precision Therapies & Real-World Evidence - EURO CLINICAL TRIALS 2026 (UK)
- Phage Therapy and Alternative Antimicrobial Strategies - Antibiotics Resistance 2027 (Spain)
- Pharma Analytical Techniques and Instrumentation - Pharmaceuticals-2027 (France)
- Pharma Market Research - MedTech-2026 (Switzerland)
- Pharmaceutical Analysis - Pharmatech 2027 (Switzerland)
- Pharmaceutical Analysis and Quality Assurance - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Pharmaceutical Analysis and Quality Control - PHARMA CONFERENCE 2026 (Spain)
- Pharmaceutical Biotechnology - Euro Pharmacology 2027 (France)
- Pharmaceutical Biotechnology and Biologics Development - Drug Safety 2027 (Italy)
- Pharmaceutical Biotechnology and Biopharmaceuticals - PHARMA CONFERENCE 2026 (Spain)
- Pharmaceutical Chemistry - Pharmatech 2027 (Switzerland)
- Pharmaceutical Drug Discovery and Development - PHARMA CONFERENCE 2026 (Spain)
- Pharmaceutical Education & Innovative Teaching - PHARMA EDUCATION 2027 (Italy)
- Pharmaceutical Industry - Pharmaceuticals-2027 (France)
- Pharmaceutical Industry - Pharmatech 2027 (Switzerland)
- Pharmaceutical Industry Trends - Pharmaceuticals-2027 (France)
- Pharmaceutical Innovation, Startups, and Industry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Pharmaceutical Manufacturing and Pharmacoeconomics - MedTech-2026 (Switzerland)
- Pharmaceutical Manufacturing, Scale Up and Tech transfer - MedTech-2026 (Switzerland)
- Pharmaceutical Nano medicine and Targeted Therapy - PHARMA CONFERENCE 2026 (Spain)
- Pharmaceutical Nanotechnology - Pharmaceuticals-2027 (France)
- Pharmaceutical Packaging - Pharmaceuticals-2027 (France)
- Pharmaceutical Packaging - Pharmaceuticals-2027 (France)
- Pharmaceutical Packaging and Logistics - MedTech-2026 (Switzerland)
- Pharmaceutical Packaging, Stability, and Shelf-Life Studies - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Pharmaceutical Process Validation and Quality by Design (QbD) - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Pharmaceutical Regulatory Affairs - Pharmaceuticals-2027 (France)
- Pharmaceutical Regulatory Sciences and Global Compliance - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Pharmaceutical Research & Translational Medicine - PHARMA EDUCATION 2027 (Italy)
- Pharmaceutical Research and Development - Pharmatech 2027 (Switzerland)
- Pharmaceutical Sciences - MedTech-2026 (Switzerland)
- Pharmaceutical Sciences - Pharmaceuticals-2027 (France)
- Pharmaceutical Technology & Manufacturing - PHARMA EDUCATION 2027 (Italy)
- Pharmaceutics and Drug Delivery Systems - PHARMA CONFERENCE 2026 (Spain)
- Pharmaceutics and Pharmacotherapeutics - Pharmatech 2027 (Switzerland)
- Pharmacists Role in Patient Safety - Pharmatech 2027 (Switzerland)
- Pharmacoeconomics - MedTech-2026 (Switzerland)
- Pharmacoeconomics - Pharmaceuticals-2027 (France)
- Pharmacoeconomics - Pharmaceuticals-2027 (France)
- Pharmacogenetics - Personalizedmedicine-2026 (Switzerland)
- Pharmacogenomics - Personalizedmedicine-2026 (Switzerland)
- Pharmacogenomics and Pharmacoepidemiology - MedTech-2026 (Switzerland)
- Pharmacogenomics and Precision Cardiovascular Medicine - Cardiovascular-2027 (France)
- Pharmacogenomics and Precision Medicine - Euro Pharmacology 2027 (France)
- Pharmacokinetics and Drug Absorption Optimization - Drug Devilvery 2027 (France)
- Pharmacokinetics and Pharmacodynamics - Pharmaceutica-2026 (Netherlands)
- Pharmacokinetics and Pharmacodynamics - Euro Pharmacology 2027 (France)
- Pharmacokinetics, Pharmacodynamics & Bioavailability - Drug Delivery 2027 (Austria)
- Pharmacology - Pharmatech 2027 (Switzerland)
- Pharmacology & Therapeutic Innovations - PHARMA EDUCATION 2027 (Italy)
- Pharmacology and Toxicology - MedTech-2026 (Switzerland)
- Pharmacology and Toxicology Research - PHARMA CONFERENCE 2026 (Spain)
- Pharmacology, Toxicology, and ADMET Studies - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Pharmacovigilance & Drug Safety in Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Pharmacovigilance & Medication Safety - PHARMA EDUCATION 2027 (Italy)
- Pharmacovigilance and drug safety - Pharmaceuticals-2027 (France)
- Pharmacovigilance and Drug Safety - Euro Pharmacology 2027 (France)
- Pharmacovigilance and Drug Safety Monitoring - Drug Safety 2027 (Italy)
- Pharmacy Practice - Pharmaceuticals-2027 (France)
- Phytochemistry - Naturalproducts 2026 (UAE)
- Population Health - Personalizedmedicine-2026 (Switzerland)
- Precision Medicine - Personalizedmedicine-2026 (Switzerland)
- Process Chemistry and Pharmaceutical Manufacturing - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Public Health and Pharmaceutical Policy - PHARMA CONFERENCE 2026 (Spain)
- Pulmonary Hypertension and Targeted Therapies - Cardiovascular-2027 (France)
- QC & QA: Quality control and Quality assurance - MedTech-2026 (Switzerland)
- Quality Assurance and Quality Control in Pharmaceutical Industries - Drug Safety 2027 (Italy)
- Quality by design (QbD) approach - MedTech-2026 (Switzerland)
- Quality Control and Regulatory Considerations in Drug Delivery Systems - Pharmaceutica-2026 (Netherlands)
- Radiopharmaceuticals - Pharmaceuticals-2027 (France)
- Rare Autoimmune and Inflammatory Diseases - ORPHAN DRUGS 2026 (France)
- Rare Neurological and Neurodevelopmental Disorders - ORPHAN DRUGS 2026 (France)
- Rare Pediatric Diseases and Neonatal Screening Advances - ORPHAN DRUGS 2026 (France)
- Real-World Evidence, Decentralized Trials & Emerging Technologies - EURO CLINICAL TRIALS 2026 (UK)
- Regenerative Medicine & Stem Cell Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Regenerative Medicine and Cardiovascular Therapeutics - Cardiovascular-2027 (France)
- Regulatory Affairs & Global Compliance in Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Regulatory Affairs & Pharmaceutical Policy - PHARMA EDUCATION 2027 (Italy)
- Regulatory Affairs and Drug Approval Systems - PHARMA CONFERENCE 2026 (Spain)
- Regulatory Affairs and Quality Assurance in Pharmaceutics - Pharmaceutica-2026 (Netherlands)
- Regulatory Affairs, Quality Compliance, and Intellectual Property - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Regulatory Authority Compliance - MedTech-2026 (Switzerland)
- Regulatory Guidelines and Global Compliance in Pharmaceuticals - Drug Safety 2027 (Italy)
- Regulatory Pharmacology and Toxicology - Euro Pharmacology 2027 (France)
- Regulatory Science, Manufacturing & Scale-Up of Drug Delivery Systems - Drug Delivery 2027 (Austria)
- Regulatory updates on Biosimilars - Eurobiosimilars 2027 (Italy)
- Regulatory, Quality Control, and Translational Aspects - Drug Devilvery 2027 (France)
- Reproductive and Developmental Toxicology - Euro Pharmacology 2027 (France)
- Risk Assessment and Safety Evaluation in Drug Development - Drug Safety 2027 (Italy)
- Smart Drug Delivery Systems - Pharmatech 2027 (Switzerland)
- Smart Polymers for Drug Delivery - Pharmaceutica-2026 (Netherlands)
- Smart, Stimuli-Responsive & Intelligent Drug Delivery - Drug Delivery 2027 (Austria)
- Stem Cell Therapy and Regenerative Medicine Applications - ORPHAN DRUGS 2026 (France)
- Supply Chain Management - Pharmaceuticals-2027 (France)
- Supply Chain Management - Pharmaceuticals-2027 (France)
- Targeted & Precision Drug Delivery - Drug Delivery 2027 (Austria)
- Targeted Oral and Gastro-Resistant Formulations - Drug Devilvery 2027 (France)
- Targeted Therapies - Personalizedmedicine-2026 (Switzerland)
- Technology in Pharma Sciences - MedTech-2026 (Switzerland)
- Telemedicine - Personalizedmedicine-2026 (Switzerland)
- Theranostics and Personalized Medicine - Drug Devilvery 2027 (France)
- Toxicology and Risk Assessment - Euro Pharmacology 2027 (France)
- Track 10: Clinical Trial Safety - Clinical Trials-2027 (UK)
- Track 10: Proteomics - Pharma Expo-2027 (France)
- Track 11: Clinical Trial Operations - Clinical Trials-2027 (UK)
- Track 11: Pharmacokinetics - Pharma Expo-2027 (France)
- Track 12. Pharmacogenomics - Pharma Expo-2027 (France)
- Track 12: Decentralized Clinical Trials - Clinical Trials-2027 (UK)
- Track 13: Microbiology - Pharma Expo-2027 (France)
- Track 13: Pharmacovigilance Quality Management - Clinical Trials-2027 (UK)
- Track 14: Metabolomics - Pharma Expo-2027 (France)
- Track 14: Safety Communication - Clinical Trials-2027 (UK)
- Track 15: Chemotherapy - Pharma Expo-2027 (France)
- Track 15: Emerging Therapies Safety - Clinical Trials-2027 (UK)
- Track 1: Bioprocessing - Pharma Expo-2027 (France)
- Track 1: Medical Device Safety - Clinical Trials-2027 (UK)
- Track 2: Immunotherapy - Pharma Expo-2027 (France)
- Track 2: Medication Errors - Clinical Trials-2027 (UK)
- Track 3: Benefit-Risk Assessment - Clinical Trials-2027 (UK)
- Track 3: Nanotechnology - Pharma Expo-2027 (France)
- Track 4: Pharmacogenomics - Pharma Expo-2027 (France)
- Track 4: Post-Marketing Safety - Clinical Trials-2027 (UK)
- Track 5: Adverse Event Reporting - Clinical Trials-2027 (UK)
- Track 5: Toxicology - Pharma Expo-2027 (France)
- Track 6: Nutraceuticals - Pharma Expo-2027 (France)
- Track 6: Pharmacovigilance Databases - Clinical Trials-2027 (UK)
- Track 7: Bioethics - Pharma Expo-2027 (France)
- Track 7: Pharmacoepidemiology - Clinical Trials-2027 (UK)
- Track 8: Drug Utilization Research - Clinical Trials-2027 (UK)
- Track 8: Pharmacovigilance - Pharma Expo-2027 (France)
- Track 9: Bioinformatics - Pharma Expo-2027 (France)
- Track 9: Patient-Reported Outcomes - Clinical Trials-2027 (UK)
- Transdermal and Topical Drug Delivery - Drug Devilvery 2027 (France)
- Translational Research - Personalizedmedicine-2026 (Switzerland)
- USFDA Approved Biosimilars - Eurobiosimilars 2027 (Italy)
- Vaccine Delivery Systems - Pharmaceutica-2026 (Netherlands)
- Vaccine Development and Immunopharmacology - Drug Safety 2027 (Italy)
- Vaccines as a Strategy to Combat AMR - Antibiotics Resistance 2027 (Spain)
- Vascular Pharmacology and Endothelial Function - Cardiovascular-2027 (France)
- Wearable and Implantable Drug Delivery Devices - Drug Devilvery 2027 (France)